Organon & Co. OGN
Set alert
At close · Oct 30
After hours · Oct 30, 4:42 PM ET
- YTD
- +93.03%
- 1 year
- +110.65%
- Open
- 13.83
- Prev close
- 13.81
- Mkt cap
- 3.63B
- Vol
- 1.85M
- Avg vol
- 2.59M
- EPS
- 0.78
- P/E
- 17.74
- Div yield
- 0.58%
More statistics
- Low
- 13.81
- High
- 13.84
- Forward P/E
- 3.79
- Beta
- 1.54
- Short ratio
- 8.54
- Inst. own
- 84.60%
- Dividend
- 0.08
- Ex-div date
- Aug 13, 2026
- 50-d avg
- 13.74
- 200-d avg
- 11.49
- 1y target
- 10.33
Discussion (6)
Sign in to join the discussion
VICKY HANUKA OGN 3 years ago #1Organon & Price Target Raised to $27.00/Share From $25.00 by Morgan Stanley
VICKY HANUKA OGN 3 years ago #2Organon & Price Target Raised to $27.00/Share From $25.00 by Morgan Stanley
VICKY HANUKA OGN 3 years ago #3Samsung Biologics and BMY to Make an Antibody Cancer Drug Substance
Moomoo 24/7
·
8 mins ago
1min
Samsung Biologics entered into an agreement with Bristol Myers Squibb (NYSE:BMY) for the large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
VICKY HANUKA OGN 3 years ago #4Samsung Biologics and BMY to Make an Antibody Cancer Drug Substance
Moomoo 24/7
·
8 mins ago
1min
Samsung Biologics entered into an agreement with Bristol Myers Squibb (NYSE:BMY) for the large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
VICKY HANUKA OGN 3 years ago #5Samsung Biologics and BMY to Make an Antibody Cancer Drug Substance
Moomoo 24/7
·
8 mins ago
1min
Samsung Biologics entered into an agreement with Bristol Myers Squibb (NYSE:BMY) for the large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
I'm still earning from my last year investment of $2,000 with Mrs Barbara , I have made up too $25,000 through her platform and it really helpful I will like to share her with you. Barbara j Lawrence on Facebook.